NASA Working Group Reviews Decompression Sickness and Thrombosis Risks for Artemis Missions
What Was Observed (Empirical Data)
NASA's Office of the Chief Health and Medical Officer convened a working group to review clinical and operational data on extravehicular activity (EVA) prebreathe protocols, in-flight venous thromboembolism (VTE) occurrences, and patent foramen ovale (PFO) implications. The evaluation synthesized prior flight medical logs and previous OCHMO recommendations to assess crew cardiovascular and decompression risks during long-duration lunar surface EVAs. No new clinical trials, orbital laboratory instrumentation, or novel statistical significances were reported in this procedural evaluation.
The Reality Check (Anti-Hype Analysis)
This release documents an internal clinical policy and risk-assessment review rather than a new empirical physiological discovery or mission emergency. It does not indicate an unprecedented medical hazard for Artemis astronauts, but instead refines existing screening and mitigation standards based on previously documented spaceflight data. The resulting outputs are procedural guidelines for exploration operations rather than peer-reviewed clinical findings.
PRIMARY SOURCE:
NASA Science Releases